COMMUNIQUÉS West-GlobeNewswire

Sienna Announces July Dividend
13/07/2018
MARKHAM, Ontario, July 13, 2018 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX:SIA) today announced a dividend of $0.075 per common share of the Company (each, a “Common Share”) for [...]
Rafael Pharmaceuticals Appoints Two Prominent Gastrointestinal Oncologists from Europe to its Medical Advisory Board to Support Global Development of CPI-613 in Pancreatic Cancer and Other Gastrointestinal Malignancies
13/07/2018
Newark, NJ, July 13, 2018 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc., a leader in the growing field of cancer metabolism-based therapeutics, today announced the appointment of Eric Van Cutsem MD, PhD and Josep [...]
Capricor Therapeutics and PPMD to Host Webinar for Duchenne Muscular Dystrophy Community on July 18
13/07/2018
Opportunity to Learn More about Company’s HOPE-2 Clinical Trial and CAP-1002 Investigational Therapy for Duchenne Muscular Dystrophy LOS ANGELES, July 13, 2018 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ:CAPR) and [...]
Exclusive CFN Media Interview: RISE Life Science Study on Cannabis and Sexual Health (Part 2)
13/07/2018
SEATTLE, July 13, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an exclusive interview [...]
Michael Auer, PT, DPT, C/NDT, is Selected to the American Health Council’s Physical Therapy Board
13/07/2018
NEW YORK, July 13, 2018 (GLOBE NEWSWIRE) -- The American Health Council selected Michael Auer, PT, DPT, C/NDT to its Physical Therapy Board. Currently a Doctor of Physical Therapy and Director of Rehabilitation Therapy [...]
Clementia Appoints Experienced Financial Executive Steve Forte as Chief Financial Officer
13/07/2018
MONTREAL, July 13, 2018 (GLOBE NEWSWIRE) -- Clementia Pharmaceuticals Inc. (NASDAQ:CMTA), a clinical-stage biopharmaceutical company innovating new treatments for people with ultra-rare bone disorders and other diseases [...]
RavenQuest Completes Oversubscribed Private Placement
13/07/2018
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWS VANCOUVER, British Columbia, July [...]
RAMSAY GENERALE DE SANTE : OPA CAPIO
13/07/2018
PRESS RELEASE THIS PRESS RELEASE MAY NOT, DIRECTLY OR INDIRECTLY, BE DISTRIBUTED OR PUBLISHED IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, OR SOUTH AFRIC A. THE OFFER IS NOT BEING MADE TO (AND [...]
RAMSAY GENERALE DE SANTE : OPA CAPIO
13/07/2018
COMMUNIQUÉ DE PRESSE LE PRESENT COMMUNIQUE DE PRESSE NE PEUT ETRE, DIRECTEMENT OU INDIRECTEMENT, DISTRIBUE OU PUBLIE EN AUSTRALIE, CANADA, HONG KONG, JAPON, NOUVELLE ZELANDE, OU AFRIQUE DU SUD. L'OFFRE N'EST PAS FAITE [...]
DBV Technologies: Half-Year Report on the DBV Technologies Liquidity Contract and Transfer to Oddo BHF
13/07/2018
AMF REGULATED INFORMATION Montrouge, France, July 13, 2018 Half-Year Report on the DBV Technologies Liquidity Contract and Transfer to Oddo BHF DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market [...]
DBV Technologies : Bilan semestriel du contrat de liquidité DBV Technologies et transfert du contrat à Oddo BHF
13/07/2018
Informations Réglementées Montrouge, France, le 13 juillet (7h30 CEST), 2018 Bilan semestriel du contrat de liquidité DBV Technologies et transfert du contrat à Oddo BHF DBV Technologies (Euronext : DBV - ISIN : [...]
ObsEva SA to start trading today on the SIX Swiss Exchange
13/07/2018
Trading of ObsEva's shares on SIX Swiss Exchange starts under the ticker symbol 'OBSN' Reference price at CHF 15.00 per share ObsEva with unique pipeline of novel and potential best-in class therapeutics to address [...]
Spero Therapeutics Announces Pricing of Securities Offering
13/07/2018
CAMBRIDGE, Mass., July 12, 2018 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments [...]
Auris Medical Prices $7 Million Public Offering
13/07/2018
Zug, Switzerland - July 12, 2018 - Auris Medical Holding AG (Nasdaq: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and mental health [...]
Precision Therapeutics Granted European Patent for its Automated, Direct-to-Drain Medical Fluid Disposal System
13/07/2018
MINNEAPOLIS , July 12, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ:AIPT) (“Precision” or “the Company”), a company focused on applying artificial intelligence to personalized medicine and drug discovery [...]
CytomX Therapeutics Announces Pricing of Public Offering of Common Stock
13/07/2018
SOUTH SAN FRANCISCO, Calif., July 12, 2018 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody [...]
Syneos Health Schedules Second Quarter 2018 Earnings Call for Thursday, August 2, 2018
13/07/2018
RALEIGH, N.C., July 12, 2018 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and CCO (Contract [...]
Helius Medical Technologies, Inc. Names Jennifer Laux as Chief Commercialization Officer
12/07/2018
NEWTOWN, Pa., July 12, 2018 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, is pleased to announce the [...]
Inspirotec Inc.: Study Results Show Allergy Patients Can Run Air Sampling Device and Determine Normal Range of Allergens in Air of Homes
12/07/2018
Results of first of its kind field study In Press in Annals of Allergy, Asthma and Immunology CHICAGO, July 12, 2018 (GLOBE NEWSWIRE) -- Inspirotec Inc., a Chicago-based startup company with proprietary technology for [...]

Pages